BioAegis Therapeutics Inc.   Report issue

For profit Phase 2
Founded: Morristown NJ United States (2011)

Organization Overview

First Clinical Trial
2018
NCT03466073
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

BioAegis Therapeutics Inc.